The Scandinavian Journal of Immunology has published a paper co-authored by dr Maja Machcińska, dr Marta Maruszewska-Cheruiyot and dr hab. Katarzyna Donskow-Łysoniewska, prof. UŁa.
The publication describes the results of a study on the expression of genes related to the Jak/STAT signalling pathway and T-cell activation in patients with relapsing- remitting multiple sclerosis (RRMS) as well as the potential impact of the disease- modifying drugs used for first- line treatment on expression of these genes.
Details of the study are described in the publication:
Szewczak, L., Machcinska, M., Kierasinska, M., Zawadzka-Więch, U., Maruszewska-Cheruiyot, M., Majewski, P., Karlinska, A., Rola, R.; Donskow-Łysoniewska, K. Expression of STAT-and T-cell-related genes in women with first-line treatment of relapsing-remitting multiple sclerosis. Scand J Immunol 2024, e13424.
